From: Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target
Biological functions | Involved processes | Mechanisms | References |
---|---|---|---|
Cell proliferation | Promotes cell cycle progression | Induces cyclin D expression and Rb hyper-phosphorylation | [117] |
Cell survival | Suppresses apoptosis | Activates MAPK signaling Activates PI3K-Akt signaling Activates the Jun-Axl-Erk signaling | |
Tumour metastasis | Cell migration and invasion | Promotes the production of MMPs Drives EMT through inducing N-cadherin and vimentin and suppressing E-cadherin | |
Stress Response | Integrated stress response as a result of unfolded/misfolded proteins or the deprivation of nutrients | Compromises calcineurin expression and calcineurin-dependent PERK phosphorylation Upregulates ATF4 expression in STC2 transgenic mice | [105] |
Immune avoidance | Functions as a metagene Compromises the activity of IFN-γ-producing CD8 + Tc1 cells | Reduces the expression of immune-associated metagenes Modulates the immunomodulatory properties of mesenchymal stem cells |